CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. OMISSIONS ARE DESIGNATED AS [***].Option and License Agreement • August 11th, 2022 • Alpine Immune Sciences, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 11th, 2022 Company IndustryThis letter serves to memorialize the agreement between AbbVie and Alpine to replace Schedule 1.157 of the Agreement with the Schedule 1.157 attached to this letter as Exhibit A.
ALPINE IMMUNE SCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 11th, 2022 • Alpine Immune Sciences, Inc. • Pharmaceutical preparations • Washington
Contract Type FiledAugust 11th, 2022 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into between Alpine Immune Sciences, Inc. (the “Company”), and Andrew Sandler (“Executive”) (collectively referred to as the “Parties” or individually as a “Party”).